|Chemical and physical data|
|Molar mass||341.36 g/mol g·mol−1|
|3D model (JSmol)|
Nitroxazepine (brand name Sintamil) is a tricyclic antidepressant (TCA) which was introduced by Ciba-Geigy (now Novartis) for the treatment of depression in India in 1982. It is also indicated for the treatment of nocturnal enuresis. Nitroxazepine acts as a serotonin-norepinephrine reuptake inhibitor and has similar effects to imipramine, but with certain advantages, such as lower anticholinergic side effects.
(TCAs and TeCAs)
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|